Literature DB >> 15709734

Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA.

Helen T Chifotides1, Kim R Dunbar.   

Abstract

This Account summarizes the DNA binding properties of anticancer active dinuclear Rh, Re, and Ru compounds. The combined results of NMR spectroscopy, X-ray crystallography, and various biochemical tools provide incontrovertible evidence that dinuclear complexes are favorably poised to bind to purine nucleobases, DNA fragments, and double-stranded DNA. Moreover, direct DNA photocleavage in vitro is effected by dirhodium compounds in the presence of electron acceptors in solution or directly attached to the dirhodium core. This research has provided valuable insight in the interactions of dinuclear compounds with DNA, knowledge that is an excellent backdrop for rational design of promising dinuclear drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709734     DOI: 10.1021/ar0302078

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  21 in total

1.  Synthesis, structure and biological activity of a new and efficient Cd(II)-uracil derivative complex system for cleavage of DNA.

Authors:  Nuria A Illán-Cabeza; Rosario A Vilaplana; Ysmael Alvarez; Khalid Akdi; Sanae Kamah; Francisco Hueso-Ureña; Miguel Quirós; Francisco González-Vílchez; Miguel N Moreno-Carretero
Journal:  J Biol Inorg Chem       Date:  2005-11-03       Impact factor: 3.358

2.  Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with ag but not with GA?

Authors:  Yogita Mantri; Stephen J Lippard; Mu-Hyun Baik
Journal:  J Am Chem Soc       Date:  2007-04-03       Impact factor: 15.419

3.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

4.  The exocyclic amino group of adenine in PtII and PdII complexes: a critical comparison of the X-ray crystallographic structural data and gas phase calculations.

Authors:  Radu Silaghi-Dumitrescu; Béla Mihály; Timea Mihály; Amr A A Attia; Pablo J Sanz Miguel; Bernhard Lippert
Journal:  J Biol Inorg Chem       Date:  2017-03-17       Impact factor: 3.358

5.  DNA binding and unwinding by self-assembled supramolecular hetero-bimetallacycles.

Authors:  Anurag Mishra; Sambandam Ravikumar; Soon Ho Hong; Hyunuk Kim; Vaishali Vajpayee; Hyewoo Lee; Byungchan Ahn; Ming Wang; Peter J Stang; Ki-Whan Chi
Journal:  Organometallics       Date:  2011-11-14       Impact factor: 3.876

6.  Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.

Authors:  Rituparna Kundu; Patrick R Cushing; Brian V Popp; Yu Zhao; Dean R Madden; Zachary T Ball
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-14       Impact factor: 15.336

7.  Study on the interaction of an anthracycline disaccharide with DNA by spectroscopic techniques and molecular modeling.

Authors:  Yan Lu; Gong-Ke Wang; Juan Lv; Gui-Sheng Zhang; Qing-Feng Liu
Journal:  J Fluoresc       Date:  2010-10-16       Impact factor: 2.217

Review 8.  The medicinal applications of imidazolium carbene-metal complexes.

Authors:  Khadijah M Hindi; Matthew J Panzner; Claire A Tessier; Carolyn L Cannon; Wiley J Youngs
Journal:  Chem Rev       Date:  2009-08       Impact factor: 60.622

9.  Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.

Authors:  Venkat Reddy Putta; Nagamani Chintakuntla; Rajender Reddy Mallepally; Srishailam Avudoddi; Nagasuryaprasad K; Deepika Nancherla; Yaswanth V V N; Prakasham R S; Satyanarayana Singh Surya; Satyanarayana Sirasani
Journal:  J Fluoresc       Date:  2015-11-10       Impact factor: 2.217

10.  A metal-based inhibitor of NEDD8-activating enzyme.

Authors:  Hai-Jing Zhong; Hui Yang; Daniel Shiu-Hin Chan; Chung-Hang Leung; Hui-Min Wang; Dik-Lung Ma
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.